Delivery Order SPE2DB20D7061-SPE2DB26FSLB8
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,579.20 for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with a completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,605.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for Spikevax 2025-26 vaccine syringes (6 months to 11 years, 0.25ML) to be delivered to the company's facility in Conshohocken, Pennsylvania by September 26, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value...
- The Defense Logistics Agency awarded a delivery order valued at $8,672.76 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (0.5mL syringes for ages 12 and up) on September 15, 2025, with completion expected by October 6, 2025. This firm fixed-price, non-set-aside contract represents a discrete purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a Delivery Order valued at $3,256.40 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) vaccine syringes at 0.25ML, with performance in Conshohocken, Pennsylvania and completion by September 25, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a $1,177.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2024-25 vaccine (12 years and up) in 0.5ml syringes, with an ultimate completion date of October 3, 2025. This is a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,096.74 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of SPIKEVAX 2025-26 (12 years and up) in 0.5ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of October 20, 2025, to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under a larger indefinite delivery contract vehicle, enabling the pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,613.65 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5mL syringes, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,083.04 delivery order on June 2, 2025, for SPIKEVAX 2024-25 vaccine (12 years and up), 0.5ML syringes, with a completion date of June 24, 2025. This competitively awarded, firm fixed-price delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,168.19 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and older, 0.5ml syringes), with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child order under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SPIKEVAX 2024-25 vaccine (12 years and up), 0.5ml syringes, with a ceiling value of $5,887.40. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB26FSLB8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,861.40 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) vaccine syringes (0.25ML) on October 30, 2025, with completion required by November 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical supply transaction supporting the Department of Defense's medical supply chain. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor supplying vaccines, medications, and medical supplies to military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates consistent capability to meet open competition requirements across diverse medical product categories and order values, positioning it as a primary supplier for DoD pharmaceutical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 10/30/25 |